🟢 Marker Therapeutics is trading 6.4% up in after-hours trading — no clear catalyst identified

Marker Therapeutics is trading at $0.98, up +6.41%, and available evidence does not establish a specific reason for its October 15 after-hours move.

• The company’s latest listed press release is dated September 22, 2026, and concerns expanded manufacturing support.
• Major indexes were mixed at the close, which does not clearly explain the stock’s gain.
• The next reported earnings date is November 12, 2026.